Washington: Elon Musk's Neuralink “blindsight chip” has performed the biggest miracle of the 21st century. With this chip, now even people who are blind in both eyes from birth or who have lost their optic nerve will be able to see the world. This chip will be implanted in the blind. The US Food and Drug Administration Department (FDA) has given permission for Elon Musk's Neuralink to implant a 'blindsight' chip. For this, the BlindSight chip has been given a breakthrough device tag by the FDA.
US tycoon Elon Musk's brain-chip startup Neuralink said on Tuesday that its experimental implant aimed at restoring vision has received the US FDA's “breakthrough device” designation. Let us tell you that the FDA's breakthrough tag is given to some medical devices that are capable of treating or diagnosing life-threatening conditions. Its purpose is to accelerate development and review tools currently under development.
After the BlindSight chip received FDA approval, Elon Musk tweeted that “This experimental device, known as BlindSight, will enable people who have lost both their eyes and their optic nerves to see.” He did not immediately respond to a request for details on how Neuralink expects the blindsight device to proceed in human trials. Let us tell you that Neuralink, founded in 2016 by Musk and a group of engineers, is building a brain chip interface that can be implanted inside the skull. Musk says that it could eventually restore vision to disabled patients as well as enable them to walk and communicate again.
What is a blindsight chip?
Neuralink's device contains a chip that processes and transmits nerve signals, which can be transmitted to devices such as computers or phones. The startup is separately testing an implant that gives paralyzed patients the ability to think independently and use digital devices. This raises the possibility that it may help patients with spinal cord injuries.
U.S. The trial is expected to enroll three patients to evaluate its device, which could take several years to complete, according to details from the government's clinical trials database. Earlier this year, Neuralink successfully implanted the device in another patient, who used it to play video games and learn how to design 3D objects.
